Navigation Links
The Meso Foundation Congratulates Representative Betty McCollum’s Efforts to Advance Mesothelioma Research
Date:12/3/2013

Alexandria, VA (PRWEB) December 03, 2013

Yesterday, U.S. Congresswomen Betty McCollum (D-MN) and Chellie Pingree (D-ME) sent a “Dear Colleague” letter to all members of the U.S. House of Representatives asking them to join them in urging the National Cancer Institute to create a scientific framework for mesothelioma. The Mesothelioma Applied Research Foundation (Meso Foundation) has long advocated for the National Cancer Institute to increase their focus on mesothelioma, and congratulates Representative McCollum and Representative Pingree for their efforts on behalf of the mesothelioma community, including patients and families, physicians, advocates, and researchers dedicated to eradicating the life-ending and vicious effects of mesothelioma.

“Congresswomen McCollum and Pingree are leading a very important effort for everyone affected by mesothelioma by encouraging the National Cancer Institute to create a scientific framework to progress mesothelioma research,” said Meso Foundation’s executive director and nurse practitioner, Mary Hesdorffer.

“This is an incredible way to help thousands of patients affected by mesothelioma, and also honor our distinguished former board member and Congresswoman McCollum’s predecessor, Bruce Vento.”

Bruce Vento, was a prominent member of Congress who, after nearly 24 years of service succumbed to mesothelioma only eight months after diagnosis.

Representative Pingree’s constituent, mesothelioma survivor Lisa Gonneville spoke at the Capitol Hill briefing on Mesothelioma Awareness Day (September 26). Mrs. Gonneville pleaded that the staffers do something to address this deadly cancer.

“I’ve endured all of the treatment options available for mesothelioma, which are very limited,” said Mrs. Gonneville, “my only hope at this point is clinical trials.”

The Recalcitrant Cancer Research Act of 2012 was signed into law by President Obama on January 2, 2013 as part of the National Defense Authorization Act (Public Law No. 112-239), giving the Director of the National Cancer Institute (NCI) the ability to identify recalcitrant cancers for which to establish scientific frameworks that will guide research efforts.

For each recalcitrant cancer, NCI is to convene a working group of both Federal and non-Federal individuals to provide expertise and assistance in developing the scientific framework. The frameworks are to be completed within 18 months of enactment, then submitted to Congress and made publicly available on the HHS website within 30 days. The bill requires the progress of each scientific framework be reported in the National Institutes of Health (NIH) Biennial Report, with an assessment of progress made in improving outcomes for recalcitrant cancers. The bill further states that the NCI Director “shall consider” each relevant scientific framework when making recommendations for exception funding for grant applications.

The Mesothelioma Applied Research Foundation has independently funded over $8.2 million in peer-reviewed mesothelioma research to date.

Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. Medical experts consider it one of the most aggressive and deadly of all cancers. Approximately 3,000 Americans are diagnosed with mesothelioma every year and an estimated one-third were exposed while serving in the Navy or working in Navy shipyards .

About The Mesothelioma Applied Research Foundation
The Meso Foundation is the leading organization dedicated to eradicating mesothelioma and easing the suffering caused by it, by funding peer-reviewed mesothelioma research, providing patient support services and education, and advocating Congress for increased federal funding for research. Mesothelioma funding, per death, has historically been extremely low, and even as recently as 2007, the NCI reported that mesothelioma receives as little as 9 times less funding than other cancers. The Meso Foundation was founded in 2000 to address this imbalance and since then has independently funded over $8.2 million in peer-reviewed mesothelioma research. More information is available at http://www.curemeso.org.
###

Read the full story at http://www.prweb.com/releases/2013/11/prweb11369700.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. 26 Year-old Biotech Headhunter with Cystic Fibrosis, Selected as One of “San Diego’s Finest” - Training for First Run Martathon to Benefit The Cystic Fibrosis Foundation
2. Giving Thanks and Giving Back I Am Waters, a Houston –based Foundation, Receives Support
3. Foundation Financial Group Supports the Wounded Warrior Project
4. Super Bowl Champions Support Living Heart Foundation HOPE Program Screening and Pro Player Health Alliance Awareness Event In New York
5. Equipment Leasing Market Place LeaseQ Comments On Recent Equipment Leasing & Finance Foundation Confidence Index
6. StartUp Health Receives Two Year Grant from Robert Wood Johnson Foundation to Accelerate Health Innovation in Underserved Communities
7. Jerry West Supports Hearing Health Awareness with the HearStrong Foundation
8. STAR Center and SPD Foundation Present Informal Webinar Sessions on Topics of Interest to Those Impacted by Sensory Processing Disorder
9. Dunn Foundation awards bioscience grants
10. Living Heart Foundation (LHF) and Screening Team Associate Pro Player Health Alliance Launch LHF HOPE Super Bowl Symposium Program December 5th In Long Island, New York
11. Study Funded by National Foundation for Cancer Research Reveals Imaging Studies May Predict Tumor Response to Anti-Angiogenic Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , ... May 25, 2016 , ... America Walks ... Carol Reichbaum, M.S.L., M.S.P.A., of the University of Pittsburgh Graduate School of Public ... will enable Ms. Reichbaum and 24 other advocates from around the country to participate ...
(Date:5/25/2016)... , ... May 25, 2016 , ... Researchers from SUNY ... COVD Meeting for their work on visual evoked potential and human attention. The article, ... that used the Diopsys® NOVA™ ERG and VEP Vision Testing System (Diopsys, ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... demand for minimally invasive, endoscopic spine surgeries in the Montgomery County, Howard County ... patients in the Germantown office of American Spine every Monday. He will also ...
(Date:5/24/2016)... , ... May 24, 2016 , ... To better understand ... new research award to examine gender differences in lung cancer. Today, the Lung Association ... Project: Lung Cancer in Women Award, funded by the American Lung Association’s LUNG FORCE ...
(Date:5/24/2016)... ... May 24, 2016 , ... United Benefit Advisors (UBA), the ... Firm Austin & Co., Inc. Headquartered in Albany, New York, Austin & ... benefits technology, and beyond. As an employee-owned company celebrating over 160 years ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 2016  Granger Diagnostics today announced immediate availability of ... infections. This test ensures discovery of ALL bacteria, ... test requires only a simple swab of the wound ... G. Bostwick , MD, Chief Medical Officer, described ... "We are excited to make available, for the ...
(Date:5/25/2016)... May 25, 2016 MedDay, a biotechnology ... that an oral presentation entitled "High doses of biotin in ... will be given by Professor Ayman Tourbah , Principal ... of the European Academy of Neurology (EAN) in ... disorders 3" will take place on Sunday, 29 May 2016 ...
(Date:5/25/2016)... May 25, 2016 ReportsnReports.com ... research report that provides an overview on therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
Breaking Medicine Technology: